Supply Chain

What's the best distribution strategy for your organization? What are the key considerations when trying to identify the optimal distribution strategy?

The FDA on March 21 shared recommendations for healthcare organizations to conserve prefilled 0.9 percent sodium chloride intravenous lock/flush syringes amid a national shortage. 

The FDA would be allowed to collect at least $1.78 billion in user fees over five years under a reauthorization of the medical device user fee program, according to a series of recommendations from the agency and representatives from the…

To help ease chronic blood shortages in the U.S., hospitals should partner with blood centers to increase donations and work with centers to host blood drives, America's Blood Centers said in a March bulletin. 

States will see a significant reduction in shipments of COVID-19 monoclonal antibody treatments from the federal government beginning March 21 as the White House's request for $15.6 billion in pandemic funding stalls in Congress, ABC News reported. 

The FDA is returning to normal facility inspection operations, which were significantly disrupted by the COVID-19 pandemic, according to a March 21 report from The New York Times.

After facing many unpredictable supply challenges in the past couple years, it’s important to carry any lessons learned into 2022. In a recent Q&A with Cardinal Health and Becker’s Hospital Review, Joe Walsh, founder of Supply Chain Sherpas, discussed how…

The FDA recently posted recall notices for four rapid COVID-19 tests recalled since Jan. 13.

Several hundred providers of Evusheld, a COVID-19 antibody treatment for immunocompromised, were removed from a federal dataset March 16, making it even more difficult to locate the therapy, Kaiser Health News reported March 17.

Medical device recalls, whether voluntary or mandated by the FDA, ensure patient safety.